Sickle Cell Disease Mortality in Brazil: Real-World Evidence

被引：2
|
作者：
Cancado, Rodolfo D. [1 ]
Costa, Fernando Ferreira [2 ]
Lobo, Clarisse [3 ]
Migliavaca, Celina Borges [4 ]
Falavigna, Maicon [4 ]
Souza Filho, Homero C. R. [5 ]
Bueno, Carolina Tosin [6 ]
Silva Pinto, Ana Cristina [7 ]
机构：
[1] Santa Casa Med Sch, Dept Hematol Oncol, Sao Paulo, Brazil
[2] Univ Estadual Campinas, Sch Med Sci, Campinas, SP, Brazil
[3] Inst Estadual Hematol Arthur Siqueira Cavalca, Rio De Janeiro, Brazil
[4] HT Analyze Consultoria & Treinamento, Porto Alegre, RS, Brazil
[5] Novartis Oncol, Dept Hematol Oncol, Sao Paulo, Brazil
[6] Novartis Oncol, Sao Paulo, Brazil
[7] Univ Sao Paulo, Ribeirao Preto Med Sch, Blood Ctr Ribeirao Preto, Ribeirao Preto, Brazil
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-151098
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3025
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Estimated mortality rates of individuals with sickle cell disease in Brazil: real-world evidence
    Cancado, Rodolfo Delfini
    Costa, Fernando Ferreira
    Lobo, Clarisse
    Migliavaca, Celina Borges
    Falavigna, Maicon
    Souza Filho, Homero C. R.
    Bueno, Carolina Tosin
    Silva-Pinto, Ana Cristina
    BLOOD ADVANCES, 2023, 7 (15) : 3783 - 3792
  • [2] Real-World Evidence on Disease Burden and Economic Impact of Sickle Cell Disease in Italy
    De Franceschi, Lucia
    Castiglioni, Chiara
    Condorelli, Claudia
    Valsecchi, Diletta
    Premoli, Eleonora
    Fiocchi, Carina
    Perrone, Valentina
    Esposti, Luca Degli
    Forni, Gian Luca
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (01)
  • [3] Real-World effectiveness of voxelotor for the treatment of sickle cell disease
    Barcelos, Giovanna
    Shah, Nirmish
    Lipato, Thokozeni
    Delea, Thomas E.
    Lonshteyn, Alexander
    Weycker, Derek
    Nguyen, Andy
    Beaubrun, Anne
    Alvarez, Ofelia
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 118 - 118
  • [4] Characterizing a Population with Severe Manifestations of Sickle Cell Disease Using US Real-World Evidence
    Paramore, Clark
    Kong, Amanda
    Minegishi, Sachiyo
    Shi, Weiliang
    BLOOD, 2018, 132
  • [5] Real-World Experience of Voxelotor for the Management of Complications in Sickle Cell Disease
    Shah, Nirmish
    Lipato, Thokozeni
    Alvarez, Ofelia A.
    Delea, Thomas
    Lonshteyn, Alexander
    Weycker, Derek
    Nguyen, Andy
    Beaubrun, Anne
    Agodoa, Irene
    BLOOD, 2021, 138
  • [6] Real-World Effectiveness of Voxelotor for Treating Sickle Cell Disease in the US
    Zaidi, Ahmar Urooj
    Lipato, Thokozeni
    Alvarez, Ofelia A.
    Lonshteyn, Alexander
    Weycker, Derek
    Pham, Nhat
    Delea, Thomas E.
    Agodoa, Irene
    Cong, Ze
    Shah, Nirmish
    BLOOD, 2020, 136
  • [7] REAL-WORLD CRIZANLIZUMAB TREATMENT PATTERNS OF PATIENTS WITH SICKLE CELL DISEASE
    Yen, G.
    Yasuda, M.
    McGuiness, C.
    He, J.
    Lee, S.
    Paulose, J.
    Chen, C. C.
    VALUE IN HEALTH, 2022, 25 (07) : S491 - S491
  • [8] Real-world experience of patients with sickle cell disease treated with crizanlizumab
    Chan, Kok Hoe
    Buddharaju, Ruhi
    Idowu, Modupe
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (02) : 242 - 247
  • [9] Voxelotor use in adults with sickle cell disease in a real-world setting
    Curtis, Susanna A.
    Betancourt, Jaime
    Kottapalli, Niharika
    Campbell, Sean
    Minniti, Caterina
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (03) : E125 - E128
  • [10] Real-world data on voxelotor to treat patients with sickle cell disease
    Muschick, Kathryn
    Fuqua, Tranaka
    Stoker-Postier, Carrianne
    Anderson, Alan R.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (02) : 154 - 161
12345